| |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Background Strain C57BL/6J Donor Strain 129S4/SvJae H2 Haplotype b Generation N6pN1 Description
Phenotypically similar to B6.129S4-Soat1tm1Far/J (003322), B6.129S4-Soat1tm1Far/Pgn has a reduced congenic interval making the closely linked Apoa2 gene of C57BL/6 rather than 129S4 origin. The donating investigator indicates that HDL levels exhibit a 24% increase on high fat diet in this strain in contrast to the 73% increase observed in the original strain. Triglyceride levels are unchanged. This strain may be useful in atherosclerosis research.Development
This strain is derived from B6.129S4-Soat1tm1Far/J (003322) by further backcrossing to C57BL/6 reducing the congenic interval to a region defined by rs4222719 and D1Mit159. The reduced interval excludes the linked gene Apoa2 from the 129S4 derived region. Dr. Beverly Paigen performed the additional backcrosses at The Jackson Laboratory; the strain was cryopreserved in 2007.
Strains carrying Soat1tm1Far allele
003322 B6.129S4-Soat1tm1Far/J 002896 B6;129S4-Soat1tm1Far/J View Strains carrying Soat1tm1Far (2 strains)
Congenic Nomenclature
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Soat1tm1Far/Soat1tm1Far
involves: 129S4/SvJae * C57BL/6
- endocrine/exocrine gland phenotype
- abnormal adrenal gland morphology (MGI Ref ID J:37049)
- adrenal glands are translucent and brownish instead of opaque and whitish-yellow as in wild-type and lack neutral lipids
- homeostasis/metabolism phenotype
- abnormal cholesterol homeostasis (MGI Ref ID J:37049)
- decrease in cholesterol esterification in fibroblasts and adrenal membranes
- esterification activity in fibroblasts is not stimulated in response to cholesterol (human LDL or 25-hydroxycholesterol)
- hepatic cholesterol ester levels are 30% lower in mutants fed a chow diet but are similar to wild-type when fed a high-fat diet
- increased circulating cholesterol level (MGI Ref ID J:37049)
- on a chow or high-fat diet, mutants have higher plasma levels of total and HDL cholesterol than wild-type
- increased circulating HDL cholesterol level (MGI Ref ID J:37049)
- abnormal lipid level (MGI Ref ID J:37049)
- reduction in cholesterol ester levels in adrenal glands and in peritoneal macrophages
- increased circulating cholesterol level (MGI Ref ID J:37049)
- on a chow or high-fat diet, mutants have higher plasma levels of total and HDL cholesterol than wild-type
- increased circulating HDL cholesterol level (MGI Ref ID J:37049)
- hematopoietic system phenotype
- abnormal macrophage morphology (MGI Ref ID J:37049)
- reduction in cholesterol ester levels in peritoneal macrophages
- immune system phenotype
- abnormal macrophage morphology (MGI Ref ID J:37049)
- reduction in cholesterol ester levels in peritoneal macrophages
- liver/biliary system phenotype
- abnormal liver morphology (MGI Ref ID J:37049)
- hepatic cholesterol ester levels are 30% lower in mutants fed a chow diet but are similar to wild-type when fed a high-fat diet
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Soat1tm1Far related
Cardiovascular Research
Atherosclerosis
Internal/Organ Research
Adrenal Cortex Defects
Metabolism Research
| Allele Symbol | Soat1tm1Far | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, RV Farese | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Acact-; Acat-1-; | ||
| Mutation Made By | Bob Farese, Gladstone Inst of Cardiovascular Disease | ||
| Strain of Origin | 129S4/SvJae | ||
| ES Cell Line Name | RF8 | ||
| ES Cell Line Strain | 129S4/SvJae | ||
| Gene Symbol and Name | Soat1, sterol O-acyltransferase 1 | ||
| Chromosome | 1 | ||
| Gene Common Name(s) | 8430426K15Rik; ACACT; ACAT; ACAT-1; ACAT1; AW550831; Acact; RIKEN cDNA 8430426K15 gene; RP11-215I23.2; SOAT; STAT; acetyl coenzyme A cholesterol acyltransferase; adrenocortical lipid depletion; ald; expressed sequence AW550831; | ||
| Molecular Note | Insertion of a neomycin cassette into a 5' early exon (amino acids 50-100). Reduced levels of a truncated mRNA transcript were detected by Northern blot on RNA from preputial glands. No protein was detected by immunoblot analysis in homogenates from preputial glands, ovaries and adrenals. [MGI Ref ID J:37049] | ||
Genotyping Protocols
Soat tm1Far, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Meiner VL; Cases S; Myers HM; Sande ER; Bellosta S; Schambelan M; Pitas RE; McGuire J; Herz J; Farese RV Jr. 1996. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A 93(24):14041-6. [PubMed: 8943057] [MGI Ref ID J:37049]
Soat1tm1Far relatedAccad M; Smith SJ; Newland DL; Sanan DA; King LE Jr; Linton MF; Fazio S; Farese RV Jr. 2000. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1 [see comments] J Clin Invest 105(6):711-9. [PubMed: 10727439] [MGI Ref ID J:61147]
Cui D; Thorp E; Li Y; Wang N; Yvan-Charvet L; Tall AR; Tabas I. 2007. Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 82(5):1040-50. [PubMed: 17576822] [MGI Ref ID J:127198]
Freeman NE; Rusinol AE; Linton M; Hachey DL; Fazio S; Sinensky MS; Thewke D. 2005. Acyl-coenzyme A:cholesterol acyltransferase promotes oxidized LDL/oxysterol-induced apoptosis in macrophages. J Lipid Res 46(9):1933-43. [PubMed: 15995174] [MGI Ref ID J:100481]
Matynia A; Anagnostaras SG; Wiltgen BJ; Lacuesta M; Fanselow MS; Silva AJ. 2008. A high through-put reverse genetic screen identifies two genes involved in remote memory in mice. PLoS ONE 3(5):e2121. [PubMed: 18464936] [MGI Ref ID J:136217]
Rodriguez A; Ashen MD; Chen ES. 2005. ACAT1 deletion in murine macrophages associated with cytotoxicity and decreased expression of collagen type 3A1. Biochem Biophys Res Commun 331(1):61-8. [PubMed: 15845358] [MGI Ref ID J:97572]
Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S. 2005. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 111(18):2373-81. [PubMed: 15851589] [MGI Ref ID J:111648]
Currently there no information available for this strain. This may be due to the supply level of this strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.